Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1Classical hematology 1CNS 1

Conditions

Brain Neoplasms 486Glioma 228Glioblastoma 224Neoplasms 62Neuroblastoma 56Central Nervous System Neoplasms 56Breast Neoplasms 54Meningioma 48Astrocytoma 43Neuroma, Acoustic 38Spinal Cord Neoplasms 35Neurofibromatosis 1 32Sarcoma 29Oligodendroglioma 29Lung Neoplasms 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Lymphoma 27Neoplasm Metastasis 26Head and Neck Neoplasms 25Melanoma 22Lymphoma, Non-Hodgkin 22Leukemia 22Meningeal Carcinomatosis 21Medulloblastoma 21Hodgkin Disease 21Burkitt Lymphoma 20Testicular Neoplasms 19Lymphoma, Follicular 19Multiple Myeloma 18Gliosarcoma 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Migraine Disorders × CNS × Clear all
NCT04196933 2025-04-16

Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma

Massachusetts Eye and Ear Infirmary

Phase NA Withdrawn
CNS

Dizziness, Migraine Disorders, Motion Sickness, Neuroma, Acoustic, Vestibular Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡